UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

The New England journal of medicine, 2017-06, Vol.376 (25), p.2427-2436

2017

Volltextzugriff (PDF)

Recombinant protein vaccines produced in insect cells

Vaccine, 2012-02, Vol.30 (10), p.1759-1766

Cox, Manon M.J

2012

Volltextzugriff (PDF)

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant

Vaccine, 2012-08, Vol.30 (36), p.5407-5416

2012

Volltextzugriff (PDF)

Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Vaccine, 2014-09, Vol.32 (42), p.5496-5502

2014

Volltextzugriff (PDF)

A fast track influenza virus vaccine produced in insect cells

Journal of invertebrate pathology, 2011-07, Vol.107, p.S31-S41

2011

Volltextzugriff (PDF)

FluBlok, a next generation influenza vaccine manufactured in insect cells

Biologicals, 2009-06, Vol.37 (3), p.182-189

2009

Volltextzugriff (PDF)

Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age

Vaccine, 2015-11, Vol.33 (48), p.6622-6628

2015

Volltextzugriff (PDF)

Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells

Biotechnology and bioengineering, 2015-11, Vol.112 (11), p.2267-2275

2015

Volltextzugriff (PDF)

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine

Vaccine, 2006-03, Vol.24 (12), p.2176-2185

2006

Volltextzugriff (PDF)

Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate

Vaccine, 2015-11, Vol.33 (44), p.6011-6016

2015

Volltextzugriff (PDF)

FluBlok, a recombinant hemagglutinin influenza vaccine

Influenza and other respiratory viruses, 2008-11, Vol.2 (6), p.211-219

2008

Volltextzugriff (PDF)

Vaccine Technology V: The art of taking vaccines to disease prevention

Vaccine, 2015-08, Vol.33 (35), p.4219-4220

2015

Volltextzugriff (PDF)

Innovations in vaccine development: can regulatory authorities keep up?

Expert review of vaccines, 2012-10, Vol.11 (10), p.1171-1173

2012

Volltextzugriff (PDF)

One-Step Purification Strategy for Cowpea Chlorotic Mottle Virus-Like Particles Produced by the IC-BEVS

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.237

2024

Volltextzugriff (PDF)

Assembly of Baculovirus Vectors for Multiplexed Prime Editing

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.301

2024

Volltextzugriff (PDF)

Construction of Recombinant Baculoviruses

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.13

2024

Volltextzugriff (PDF)

Recombinant AAV Purification

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.217

2024

Volltextzugriff (PDF)

Production of Recombinant Viral Antigens Using the Baculovirus-Insect Cell Expression System

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.185

2024

Volltextzugriff (PDF)

Purification Process for a Secreted Protein Produced in Insect Cells

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.247

Chubet, Richard G

2024

Volltextzugriff (PDF)

Functional Baculovirus Particle Quantification via Plaque Assay

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.259

2024

Volltextzugriff (PDF)

Nonviral Platform for Expression of Recombinant Protein in Insect Cells

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.289

2024

Volltextzugriff (PDF)

A Microsphere Immunoassay for the Quantitative Detection of Antigens in Cell Culture Supernatant

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.277

2024

Volltextzugriff (PDF)

Adaptive Laboratory Evolution to Improve Recombinant Protein Production Using Insect Cells

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.79

2024

Volltextzugriff (PDF)

TOPO Cloning for Efficient Plasmid Construction

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.67

2024

Volltextzugriff (PDF)

Probing Baculovirus Vector Gene Essentiality for Foreign Gene Expression Using a CRISPR-Cas9 System

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2829, p.127

2024

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Animals
(40)
Humans
(30)
Baculoviridae - Genetics
(27)
Baculovirus
(27)
Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Influenza
(19)
Cell Line
(17)
Genetic Vectors - Genetics
(17)
Recombinant Proteins - Genetics
(17)
Sf9 Cells
(17)
Vaccines
(17)
Influenza Vaccines - Immunology
(16)
Immunology
(14)
Insect Cells
(12)
Antigens
(11)
Influenza, Human - Prevention & Control
(10)
Medicine, Research & Experimental
(10)
Research & Experimental Medicine
(10)
Vaccine
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

Recombinant protein vaccines produced in insect cells

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant

Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

A fast track influenza virus vaccine produced in insect cells

FluBlok, a next generation influenza vaccine manufactured in insect cells

Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age

Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine

Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate

FluBlok, a recombinant hemagglutinin influenza vaccine

Vaccine Technology V: The art of taking vaccines to disease prevention

Innovations in vaccine development: can regulatory authorities keep up?

One-Step Purification Strategy for Cowpea Chlorotic Mottle Virus-Like Particles Produced by the IC-BEVS

Assembly of Baculovirus Vectors for Multiplexed Prime Editing

Construction of Recombinant Baculoviruses

Recombinant AAV Purification

Production of Recombinant Viral Antigens Using the Baculovirus-Insect Cell Expression System

Purification Process for a Secreted Protein Produced in Insect Cells

Functional Baculovirus Particle Quantification via Plaque Assay

Nonviral Platform for Expression of Recombinant Protein in Insect Cells

A Microsphere Immunoassay for the Quantitative Detection of Antigens in Cell Culture Supernatant

Adaptive Laboratory Evolution to Improve Recombinant Protein Production Using Insect Cells

TOPO Cloning for Efficient Plasmid Construction

Probing Baculovirus Vector Gene Essentiality for Foreign Gene Expression Using a CRISPR-Cas9 System

Suchergebnisse filtern